Effects of a Cognitive Behavioral Digital Therapeutic on Anxiety and Depression Symptoms in Patients With Cancer: A Randomized Controlled Trial
JCO Oncology Practice · 2023-12 · 19 (12) · 1179-1189
DOI: 10.1200/op.23.00210 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JCO Oncology Practice, 2023-12. Verfasst von Sean R Zion und 10 weiteren Autor:innen. Beteiligte Einrichtung: Blue Note Therapeutics, San Francisco, CA. Hauptthemen laut MEDLINE: Breast Neoplasms, Cognitive Behavioral Therapy. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Depression
Abstract (Originalsprache)
Results from a clinical trial of a new cognitive behavioral stress management (CBSM) app show a significant benefit for patients with cancer with symptoms of anxiety and depression. The double-blind, randomized controlled trial compared the cancer-specific app with a health education sham app in 449 patients diagnosed with nonmetastatic cancers. Patients who received the cancer-specific app showed significantly greater reductions in symptoms of anxiety and depression over 12 weeks and were significantly more likely to report their symptoms as much or very much improved at the end of the study. Self-reported adverse events were also collected to inform benefit-risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Blue Note Therapeutics, San Francisco, CA.
- King's College London, London, United Kingdom.
- University of Miami, Coral Gables, FL.
- University of California Los Angeles, Los Angeles, CA.
- University of California San Francisco, San Francisco, CA.
ORCID-Profile: Sean R Zion, Chloe J Taub, Lauren C Heathcote, Allison Ramiller, Stacey Tinianov, Frank J Penedo, Patricia A Ganz, Michael Antoni, Dianne M Shumay
Zitieren
APA
Zion, S. R., Taub, C. J., Heathcote, L. C., Ramiller, A., Tinianov, S., McKinley, M., Eich, G., Penedo, F. J., Ganz, P. A., Antoni, M., & Shumay, D. M. (2023). Effects of a Cognitive Behavioral Digital Therapeutic on Anxiety and Depression Symptoms in Patients With Cancer: A Randomized Controlled Trial. JCO Oncology Practice, 19(12), 1179-1189. https://doi.org/10.1200/op.23.00210
Vancouver
Zion SR, Taub CJ, Heathcote LC, Ramiller A, Tinianov S, McKinley M, et al. Effects of a Cognitive Behavioral Digital Therapeutic on Anxiety and Depression Symptoms in Patients With Cancer: A Randomized Controlled Trial. JCO Oncology Practice. 2023;19(12):1179-1189. doi:10.1200/op.23.00210
BibTeX
@article{Zion2023,
author = {Zion, Sean R and Taub, Chloe J and Heathcote, Lauren C and Ramiller, Allison and Tinianov, Stacey and McKinley, Michael and Eich, Geoff and Penedo, Frank J and Ganz, Patricia A and Antoni, Michael and Shumay, Dianne M},
title = {Effects of a Cognitive Behavioral Digital Therapeutic on Anxiety and Depression Symptoms in Patients With Cancer: A Randomized Controlled Trial},
journal = {JCO Oncology Practice},
year = {2023},
volume = {19},
number = {12},
pages = {1179--1189},
doi = {10.1200/op.23.00210}
}
EUVIMED